Compare SSMR & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSMR | INSP |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2026 | 2018 |
| Metric | SSMR | INSP |
|---|---|---|
| Price | $12.36 | $68.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 18 |
| Target Price | $19.17 | ★ $68.00 |
| AVG Volume (30 Days) | 534.5K | ★ 670.8K |
| Earning Date | 11-17-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $11.38 | $38.91 |
| 52 Week High | $19.61 | $147.03 |
| Indicator | SSMR | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 46.32 |
| Support Level | $11.38 | $67.10 |
| Resistance Level | $15.33 | $73.69 |
| Average True Range (ATR) | 1.01 | 2.49 |
| MACD | 0.11 | -0.24 |
| Stochastic Oscillator | 31.45 | 19.05 |
Sunshine Silver Mining & Refining Co is a mining exploration and development company. It owns and develops the Sunshine Mine, the Sunshine Silver/Copper Refinery, and related facilities, including the Sunshine Tailings Storage Facility and historical antimony refinery grounds. The Sunshine Mine is a permitted past-producing silver mine in the United States that has historically produced silver, antimony, copper, and lead.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.